Papain: NF 4-608 B NF 4-6152 NUTRA 6-452 PAPAIN PROHYDROXY NF 4-714

Specialty Enzymes & Biotechnologies recalled Papain: in a Class II action, the FDA tier for products that may cause temporary or medically reversible health effects on Oct 3, 2013.

The FDA-published reason for this recall is: "Specialty Enzymes and Biotechnologies is recalling cellulase/mannanase and fungal protease because they may contain low levels of chloramphenicol."

Distribution was broad: the FDA record describes it as "Nationwide in US and worldwide to: Australia, Canada, Malaysia, Taiwan, Italy," which places this among the wider-reach recalls on the site. Consumers across the affected area should check product on hand. The recalling firm is based in Chino, CA. The recall covers 625 kg of product. The FDA has Terminated this recall (first reported Nov 20, 2013), its final lifecycle state, indicating the agency considers the corrective action resolved. The historical record remains useful for tracking a brand's recall pattern over time.